Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 They also showed differences in the corresponding responses, but in a different manner: in their hands, the magnitude and the secondary response of the CD8 + T cells were affected by the duration of antigenic stimulation, but not the functionality of effector cells (Prlic et al., 2006). In another model, the authors blocked antigen presentation by using anti-K b - SIINFEKL MHC-peptide complexe antibody in order to assess the effect of modulating the duration of MHC-peptide complexe signaling on T cell responsiveness. They demonstrated that altering this interaction affected both T cell expansion and the differentiation into memory T cells (Obar and Lefrancois, 2010). Interestingly, different and sometimes even opposite results have been reported in answer to these questions, seemingly dependent on the model used to modulate antigen persistence. Based on our results about persistence of antigen and its relation to cross-presentation, we can consider, for our comparisons, the i.v. condition as a brief stimulation and the i.d. condition as sustained antigen stimulation (Figure 32, cohort 3). We observed a similar expansion of T cells in both conditions, but a qualitatively better primary response and a more robust secondary response after a sustained stimulation. These results are in accordance with previous papers showing that the duration of antigenic stimulation can impact CD8 + T cell differentiation. However, different and even opposite results have also been described depending on the model used to modulate antigen persistence. Another approach used in our lab to modulate persistence of antigen has also led to controversial results. Previous work in our lab, comparing cross-priming after immunization with WT or β2m -/- splenocytes demonstrated that persistence of antigen is crucial for efficient priming. Indeed β2m -/- are rapidly killed by NK cells, resulting in their removal. Cross-priming is much more efficient after immunization with WT than β2m -/- splenocytes, suggesting that the ability of the WT cells to stay in the tissue contributed to the increased efficiency of cross-priming. Furthermore, efficient cross- priming was restored in the β2m -/- immunization conditions, but only if NK cells were depleted, allowing for the β2m -/- cells to persist (Jusforgues-Saklani et al., 2008). In contrast, Krebs and colleagues demonstrated the opposite effects of NK killing in an Ovalbumin model. They immunized mice with K b-/- mOva splenocytes that are also targets for NK cells. However, in this setting, they observed more efficient priming when NK cells were present, suggesting a role for NK cells in the killing of cell-associated antigen and providing antigen to APCs (Krebs et al., 2009). From the results described here we can conclude that the model used to study antigen persistence is a critical factor to take into account when studying the modulation of T cell 150
tel-00827710, version 1 - 29 May 2013 priming: in vitro versus in vivo study, the antigenic model used, the role of NK cells, the removal of DCs via CD11c-DTR mice treated with diphteria toxin versus the inhibition blocking of antigen presentation with blocking antibodies. Each of these approaches modulate antigen persistence, but at a different level, and may also impact other aspects of immune response at the same time. Our model would clearly benefit from further understanding regarding how H-2K bm1 mOva cells are killed after injection, as this would allow us to better control persistence of antigen and, as a result, understand whether persistence of live cell-associated antigen is a crucial parameter for the robustness of the response. In parallel, the use of splenocytes expressing the receptor for the diphteria toxin as the cell- associated antigen may help us to address this question. It would permit the removal of antigen at different time points post-immunization by injecting diphteria toxin and investigate the quality of the subsequent response in these differing conditions. The aim here would be to block antigen persistence upon i.d. immunization and observe whether we obtain a response similar to what we observed after i.v. immunization. This idea was the aim of our experiments using the K b -SIINFEKL antibody to block antigen presentation. The opposite approach could also be investigated and would involve mimicking antigen persistence after i.v. immunization (by several successive antigen injections for instance) and examine whether we are able to improve the quality of the resulting T cell response. 4) A role for CD4 help? CD4 help has been shown crucial for the initiation of a completely functional CD8 + T cell response (Bennett et al., 1997), especially for effective cross-priming. However it has been demonstrated in a tumor model that CD4 help may or may not be required depending on the route of immunization. Bour and colleagues compared i.d. and i.p. injection of tumor cells and observed that an anti-tumor CD8 + T cell response developed without CD4 + help after i.d. immunization, whereas help was required after i.p. immunization (Bour et al., 1998). We investigated the necessity of CD4 + help using a variety of different approaches in our model: in particular we transferred low numbers of TCR-transgenic specific OT-II CD4 + T cells. We also tried to stain endogenous antigen-specific CD4+ T cells using MHC-II-peptide tetramers. However, we were not able to detect specific cells in a reproducible way. The role of these cells need to be further investigated. Page 151 of 256
- Page 99 and 100: tel-00827710, version 1 - 29 May 20
- Page 101 and 102: tel-00827710, version 1 - 29 May 20
- Page 103 and 104: tel-00827710, version 1 - 29 May 20
- Page 105 and 106: tel-00827710, version 1 - 29 May 20
- Page 107 and 108: tel-00827710, version 1 - 29 May 20
- Page 109 and 110: tel-00827710, version 1 - 29 May 20
- Page 111 and 112: tel-00827710, version 1 - 29 May 20
- Page 113 and 114: tel-00827710, version 1 - 29 May 20
- Page 115 and 116: tel-00827710, version 1 - 29 May 20
- Page 117 and 118: tel-00827710, version 1 - 29 May 20
- Page 119 and 120: tel-00827710, version 1 - 29 May 20
- Page 121 and 122: tel-00827710, version 1 - 29 May 20
- Page 123 and 124: tel-00827710, version 1 - 29 May 20
- Page 125 and 126: tel-00827710, version 1 - 29 May 20
- Page 127 and 128: tel-00827710, version 1 - 29 May 20
- Page 129 and 130: tel-00827710, version 1 - 29 May 20
- Page 131 and 132: tel-00827710, version 1 - 29 May 20
- Page 133 and 134: tel-00827710, version 1 - 29 May 20
- Page 135 and 136: tel-00827710, version 1 - 29 May 20
- Page 137 and 138: tel-00827710, version 1 - 29 May 20
- Page 139 and 140: tel-00827710, version 1 - 29 May 20
- Page 141 and 142: tel-00827710, version 1 - 29 May 20
- Page 143 and 144: tel-00827710, version 1 - 29 May 20
- Page 145 and 146: tel-00827710, version 1 - 29 May 20
- Page 147 and 148: tel-00827710, version 1 - 29 May 20
- Page 149: tel-00827710, version 1 - 29 May 20
- Page 153 and 154: tel-00827710, version 1 - 29 May 20
- Page 155 and 156: tel-00827710, version 1 - 29 May 20
- Page 157 and 158: tel-00827710, version 1 - 29 May 20
- Page 159 and 160: tel-00827710, version 1 - 29 May 20
- Page 161 and 162: tel-00827710, version 1 - 29 May 20
- Page 163 and 164: tel-00827710, version 1 - 29 May 20
- Page 165 and 166: tel-00827710, version 1 - 29 May 20
- Page 167 and 168: tel-00827710, version 1 - 29 May 20
- Page 169 and 170: tel-00827710, version 1 - 29 May 20
- Page 171 and 172: tel-00827710, version 1 - 29 May 20
- Page 173 and 174: tel-00827710, version 1 - 29 May 20
- Page 175 and 176: tel-00827710, version 1 - 29 May 20
- Page 177 and 178: tel-00827710, version 1 - 29 May 20
- Page 179 and 180: tel-00827710, version 1 - 29 May 20
- Page 181 and 182: tel-00827710, version 1 - 29 May 20
- Page 183 and 184: tel-00827710, version 1 - 29 May 20
- Page 185 and 186: tel-00827710, version 1 - 29 May 20
- Page 187 and 188: tel-00827710, version 1 - 29 May 20
- Page 189 and 190: tel-00827710, version 1 - 29 May 20
- Page 191 and 192: tel-00827710, version 1 - 29 May 20
- Page 193 and 194: tel-00827710, version 1 - 29 May 20
- Page 195 and 196: tel-00827710, version 1 - 29 May 20
- Page 197 and 198: tel-00827710, version 1 - 29 May 20
- Page 199 and 200: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
They also showed differences in the corresponding responses, but in a different manner: in<br />
their hands, the magnitu<strong>de</strong> and the secondary response of the CD8 + T cells were affected by<br />
the duration of antigenic stimulation, but not the functionality of effector cells (Prlic <strong>et</strong> al.,<br />
2006). In another mo<strong>de</strong>l, the authors blocked antigen presentation by using anti-K b -<br />
SIINFEKL MHC-pepti<strong>de</strong> complexe antibody in or<strong>de</strong>r to assess the effect of modulating the<br />
duration of MHC-pepti<strong>de</strong> complexe signaling on T cell responsiveness. They <strong>de</strong>monstrated<br />
that altering this interaction affected both T cell expansion and the differentiation into<br />
memory T cells (Obar and Lefrancois, 2010). Interestingly, different and som<strong>et</strong>imes even<br />
opposite results have been reported in answer to these questions, seemingly <strong>de</strong>pen<strong>de</strong>nt on the<br />
mo<strong>de</strong>l used to modulate antigen persistence.<br />
Based on our results about persistence of antigen and its relation to cross-presentation, we can<br />
consi<strong>de</strong>r, for our comparisons, the i.v. condition as a brief stimulation and the i.d. condition as<br />
sustained antigen stimulation (Figure 32, cohort 3). We observed a similar expansion of T<br />
cells in both conditions, but a qualitatively b<strong>et</strong>ter primary response and a more robust<br />
secondary response after a sustained stimulation. These results are in accordance with<br />
previous papers showing that the duration of antigenic stimulation can impact CD8 + T cell<br />
differentiation.<br />
However, different and even opposite results have also been <strong>de</strong>scribed <strong>de</strong>pending on the<br />
mo<strong>de</strong>l used to modulate antigen persistence. Another approach used in our lab to modulate<br />
persistence of antigen has also led to controversial results. Previous work in our lab,<br />
comparing cross-priming after immunization with WT or β2m -/- splenocytes <strong>de</strong>monstrated<br />
that persistence of antigen is crucial for efficient priming. In<strong>de</strong>ed β2m -/- are rapidly killed by<br />
NK cells, resulting in their removal. Cross-priming is much more efficient after immunization<br />
with WT than β2m -/- splenocytes, suggesting that the ability of the WT cells to stay in the<br />
tissue contributed to the increased efficiency of cross-priming. Furthermore, efficient cross-<br />
priming was restored in the β2m -/- immunization conditions, but only if NK cells were<br />
<strong>de</strong>pl<strong>et</strong>ed, allowing for the β2m -/- cells to persist (Jusforgues-Saklani <strong>et</strong> al., 2008). In contrast,<br />
Krebs and colleagues <strong>de</strong>monstrated the opposite effects of NK killing in an Ovalbumin<br />
mo<strong>de</strong>l. They immunized mice with K b-/- mOva splenocytes that are also targ<strong>et</strong>s for NK cells.<br />
However, in this s<strong>et</strong>ting, they observed more efficient priming when NK cells were present,<br />
suggesting a role for NK cells in the killing of cell-associated antigen and providing antigen<br />
to APCs (Krebs <strong>et</strong> al., 2009).<br />
From the results <strong>de</strong>scribed here we can conclu<strong>de</strong> that the mo<strong>de</strong>l used to study antigen<br />
persistence is a critical factor to take into account when studying the modulation of T cell<br />
150